作者: Erin E. Bonar , Lisham Ashrafioun , Mark A. Ilgen
DOI: 10.1016/J.DRUGALCDEP.2014.07.009
关键词:
摘要: BACKGROUND: The abuse of synthetic cannabinoids has emerged as a public health concern over the past few years, yet little data exist characterizing use cannabinoids, particularly among patients seeking substance disorder (SUD) treatment. In sample entering residential SUD treatment, we examined prevalence and motivations for cannabinoid use, relationships with other demographic characteristics. METHODS: Patients (N=396; 67% male, 75% White, Mage=34.8) completed self-report screening surveys about lifetime route administration, motives use. RESULTS: A total 150 (38%) reported using in their lifetimes, primarily by smoking (91%). Participants chose multiple most commonly endorsed included curiosity (91%), feeling good/getting high (89%), relaxation (71%), getting without having positive drug test (71%). Demographically, those who used were younger more White. They had higher rates scores on measures depression psychiatric distress. CONCLUSIONS: Lifetime was relatively common many it doing so because they believed would not result test. Further research is needed to characterize extent treatment samples, establish understanding longitudinal trajectories combination distress, outcomes. Language: en